Indications and uses
to temporarily relieve symptoms commonly associated with seasonal depression such as: melancholy sadness worthlessness discouragement
to temporarily relieve symptoms commonly associated with seasonal depression such as: melancholy sadness worthlessness discouragement
Dispense MoodBrite directly into mouth, or add recommended dosage into 8-12 oz. purified (non-chlorinated) water and drink. Safe for ages 2 and up. DOSAGE BY WEIGHT 30-50 lbs 1/2 mL (13.6-22.6 kg) twice per day 50+ lbs 1 mL (22.6+ kg) twice per day
do not use if tamper seal is broken store in a cool, dry place product must not come in contact with metal do not store next to electrical devices or appliances
| Anacardium orientale, Larix decidua, flos HPUS |
Aurum metallicum HPUS |
Avena sativa HPUS |
Calcarea carbonica HPUS |
Carpinus betulus, flos, Phosphorus, HPUS |
Cimicifuga racemosa, Natrum carbonicum HPUS Cinchona officinalis HPUS |
Hypericum perforatum, Kali bromatum, Natrum sulphuricum, Tabacum HPUS |
Ignatia amara, Pulsatilla, Sepia, Sinapis arvensis, flos HPUS |
| Phosphoricum acidum
HPUS
Each active ingredient contains equal volumes of 10X, 30X and LM1 potencies. The letters "HPUS" indicate that the components in this product are officially monographed in the Homeopathic Pharmacopoeia of the United States. Product indications are based on Homeopathic Materia Medica. |
| Anacardium orientale, Larix decidua, flos HPUS.............................................................................................Lack of self-confidence |
| Aurum metallicum HPUS..................................................................................................................................Worthlessness |
| Avena sativa HPUS........................................................................................................................................ Nervous exhaustion |
| Calcarea carbonica HPUS..............................................................................................................................Apprehension |
| Carpinus
betulus, flos, Phosphorus, HPUS....................................................................................................Indifference
Cimicifuga racemosa, Natrum carbonicum HPUS............................................................................................Worry |
| Cinchona officinalis HPUS...............................................................................................................................Discouragement |
| Hypericum perforatum, Kali bromatum, Natrum sulphuricum, Tabacum HPUS...............................................Melancholy |
| Ignatia amara, Pulsatilla, Sepia, Sinapis arvensis, flos HPUS.........................................................................Sadness |
| Phosphoricum acidum HPUS...........................................................................................................................Grief |
to temporarily relieve symptoms commonly associated with seasonal depression such as:
|
Ask a doctor before use if • you are taking any other medications • you have a medical condition |
When using this product use only as directed.
| Stop use and ask a doctor if symptoms persist or worsen.
|
If pregnant or breast-feeding, ask a health professional before use.
Keep out of the reach of children.
Dispense MoodBrite directly into mouth, or add recommended dosage into 8-12 oz. purified (non-chlorinated) water and drink. Safe for ages 2 and up.
DOSAGE BY WEIGHT
30-50 lbs 1/2 mL
(13.6-22.6 kg) twice per day
50+ lbs 1 mL
(22.6+ kg) twice per day
| citric acid, potassium sorbate, purified ionized mineral water |
You can email us at
info@hellolife.net or
call us toll-free at
1.800.875.0850
Monday
through Friday 9am-5pm ET
| • 30-day supply
• dropper included • MoodBrite is made without alcohol or sugar. No gluten added. Mftd for: HelloLife, LLC. 4460 44th St SE, Ste. C-600 Grand Rapids, MI 49512 FDA Pharmaceutical Establishment #1053442, #3009727070 |
NDC 49726-031-02 MOODBRITE TM
2 fl oz (59 mL) Homeopathic (OTC) Medicine |
| Product concept | Relation | Version | Effective |
|---|---|---|---|
| 95250459-30e4-45c1-b08a-993044f49109 | Product name | 2 | 20250805 |
| 362d7abb-94e6-4c60-9a58-266894157713 | Product name | 1 | 20231023 |
| 9badc7be-250a-44ab-aa36-926af3f02679 | Product name | 1 | 20210527 |
| 816b97af-edc5-4060-aff1-b814bdbcad50 | Product name | 1 | 20190415 |
| 26acd337-b838-40ac-bcbc-05c3b81c8712 | Product name | 1 | 20170323 |
| NDC | Effective | Action | Document | Indexing SPL | Related label |
|---|---|---|---|---|---|
| 49726-031-02 | 2020-01-31 | C162847 | 48780-1 | 9d75b9d0-f95e-f424-e053-dadaa90a57ce | 5493cd3d-a021-4832-8941-27d2d7b625eb |
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 49726-031-02 | MoodBriteSeasonal Depression Symptom Relief | 59 mL in 1 BOTTLE, DROPPER | LIQUID | 59 | 8 | |
| 49726-031-02 | MoodBriteSeasonal Depression Symptom Relief | 1 in 1 CARTON | LIQUID | 1 | 8 |
| NDC | Dashboard title | SPL version | Validation | Dashboard ZIP |
|---|---|---|---|---|
| 49726-031 | MOODBRITE SEASONAL DEPRESSION SYMPTOM RELIEF (ANACARDIUM ORIENTALE, LARIX DECIDUA, FLOS, AURUM METALLICUM, AVENA SATIVA, CALCAREA CARBONICA, CINCHONA OFFICINALIS, HYPERICUM PERFORATUM, KALI BROMATUM, NATRUM SULPHURICUM, TABACUM, IGNATIA AMARA, PULSATILLA, SEPIA, SINAPIS ARVENSIS, FLOS, CIMICIFUGA RACEMOSA, NATRUM CARBONICUM, PHOSPHORICUM ACIDUM, PHOSPHORUS, CARPINUS BETULUS, FLOS) LIQUID [HELLO LIFE, INC.] | 8 | Legacy NDC, 2 package rows | 20181227_5493cd3d-a021-4832-8941-27d2d7b625eb.zip |
| Ingredient | Type | UNII | SPL version | Uploaded |
|---|---|---|---|---|
| AVENA SATIVA FLOWERING TOP | ACTIVE INGREDIENT | MA9CQJ3F7F | 6 | |
| BLACK COHOSH | ACTIVE INGREDIENT | K73E24S6X9 | 6 | |
| CARPINUS BETULUS FLOWERING TOP | ACTIVE INGREDIENT | QOI241B01F | 6 | |
| CINCHONA OFFICINALIS BARK | ACTIVE INGREDIENT | S003A158SB | 6 | |
| GOLD | ACTIVE INGREDIENT | 79Y1949PYO | 6 | |
| HYPERICUM PERFORATUM | ACTIVE INGREDIENT | XK4IUX8MNB | 6 | |
| LARIX DECIDUA FLOWERING TOP | ACTIVE INGREDIENT | 9UMZ642257 | 6 | |
| OYSTER SHELL CALCIUM CARBONATE, CRUDE | ACTIVE INGREDIENT | 2E32821G6I | 6 | |
| PHOSPHORIC ACID | ACTIVE INGREDIENT | E4GA8884NN | 6 | |
| PHOSPHORUS | ACTIVE INGREDIENT | 27YLU75U4W | 6 | |
| POTASSIUM BROMIDE | ACTIVE INGREDIENT | OSD78555ZM | 6 | |
| PULSATILLA VULGARIS | ACTIVE INGREDIENT | I76KB35JEV | 6 | |
| SEMECARPUS ANACARDIUM JUICE | ACTIVE INGREDIENT | Y0F0BU8RDU | 6 | |
| SEPIA OFFICINALIS JUICE | ACTIVE INGREDIENT | QDL83WN8C2 | 6 | |
| SINAPIS ARVENSIS FLOWERING/FRUITING TOP | ACTIVE INGREDIENT | WWX61E1ZAK | 6 | |
| SODIUM CARBONATE | ACTIVE INGREDIENT | 45P3261C7T | 6 | |
| SODIUM SULFATE | ACTIVE INGREDIENT | 0YPR65R21J | 6 | |
| STRYCHNOS IGNATII SEED | ACTIVE INGREDIENT | 1NM3M2487K | 6 | |
| TOBACCO LEAF | ACTIVE INGREDIENT | 6YR2608RSU | 6 | |
| AVENA SATIVA FLOWERING TOP | ACTIVE MOIETY | MA9CQJ3F7F | 6 | |
| BLACK COHOSH | ACTIVE MOIETY | K73E24S6X9 | 6 | |
| BROMIDE ION | ACTIVE MOIETY | 952902IX06 | 6 | |
| CARBONATE ION | ACTIVE MOIETY | 7UJQ5OPE7D | 6 | |
| CARPINUS BETULUS FLOWERING TOP | ACTIVE MOIETY | QOI241B01F | 6 | |
| CINCHONA OFFICINALIS BARK | ACTIVE MOIETY | S003A158SB | 6 | |
| GOLD | ACTIVE MOIETY | 79Y1949PYO | 6 | |
| HYPERICUM PERFORATUM | ACTIVE MOIETY | XK4IUX8MNB | 6 | |
| LARIX DECIDUA FLOWERING TOP | ACTIVE MOIETY | 9UMZ642257 | 6 | |
| OYSTER SHELL CALCIUM CARBONATE, CRUDE | ACTIVE MOIETY | 2E32821G6I | 6 | |
| PHOSPHORIC ACID | ACTIVE MOIETY | E4GA8884NN | 6 | |
| PHOSPHORUS | ACTIVE MOIETY | 27YLU75U4W | 6 | |
| PULSATILLA VULGARIS | ACTIVE MOIETY | I76KB35JEV | 6 | |
| SEMECARPUS ANACARDIUM JUICE | ACTIVE MOIETY | Y0F0BU8RDU | 6 | |
| SEPIA OFFICINALIS JUICE | ACTIVE MOIETY | QDL83WN8C2 | 6 | |
| SINAPIS ARVENSIS FLOWERING/FRUITING TOP | ACTIVE MOIETY | WWX61E1ZAK | 6 | |
| SODIUM SULFATE ANHYDROUS | ACTIVE MOIETY | 36KCS0R750 | 6 | |
| STRYCHNOS IGNATII SEED | ACTIVE MOIETY | 1NM3M2487K | 6 | |
| TOBACCO LEAF | ACTIVE MOIETY | 6YR2608RSU | 6 | |
| ANHYDROUS CITRIC ACID | INACTIVE INGREDIENT | XF417D3PSL | 6 | |
| POTASSIUM SORBATE | INACTIVE INGREDIENT | 1VPU26JZZ4 | 6 | |
| WATER | INACTIVE INGREDIENT | 059QF0KO0R | 6 |
Every source-derived product name is available through these pages.
| Product NDC | Package NDC |
|---|---|
| 49726-031 | 49726-031-02 |
Every source-derived ingredient row is available through these pages.
Inactive Ingredient Database values describe FDA-listed use contexts. The match method and ambiguity count are shown because ingredient names, routes, and dosage forms are not always unique. Browse recovered IID releases and source provenance.
| DailyMed ingredient | IID ingredient | UNII | Dosage form / route | Potency | Maximum daily exposure | Match |
|---|---|---|---|---|---|---|
| ANHYDROUS CITRIC ACID | ANHYDROUS CITRIC ACID | XF417D3PSL | SPRAY, METERED / NASAL | 1.2 mg/1ml | ||
| ANHYDROUS CITRIC ACID | ANHYDROUS CITRIC ACID | XF417D3PSL | TABLET / ORAL | 197 mg | ||
| POTASSIUM SORBATE | POTASSIUM SORBATE | 1VPU26JZZ4 | TABLET, COATED / ORAL | NA | ||
| ANHYDROUS CITRIC ACID | ANHYDROUS CITRIC ACID | XF417D3PSL | TABLET / SUBLINGUAL | 36 mg | ||
| ANHYDROUS CITRIC ACID | ANHYDROUS CITRIC ACID | XF417D3PSL | SPRAY / TOPICAL | 0.01 %w/w | ||
| ANHYDROUS CITRIC ACID | ANHYDROUS CITRIC ACID | XF417D3PSL | INJECTION, POWDER, FOR SOLUTION / INTRAVENOUS | 35 mg | ||
| ANHYDROUS CITRIC ACID | ANHYDROUS CITRIC ACID | XF417D3PSL | INJECTION, SOLUTION / INTRAVENOUS | 772 mg | ||
| ANHYDROUS CITRIC ACID | ANHYDROUS CITRIC ACID | XF417D3PSL | PASTE / ORAL | 26 mg | ||
| ANHYDROUS CITRIC ACID | ANHYDROUS CITRIC ACID | XF417D3PSL | SUSPENSION, EXTENDED RELEASE / ORAL | 62 mg | ||
| ANHYDROUS CITRIC ACID | ANHYDROUS CITRIC ACID | XF417D3PSL | SUSPENSION/ DROPS / ORAL | 15 mg | ||
| ANHYDROUS CITRIC ACID | ANHYDROUS CITRIC ACID | XF417D3PSL | TABLET, EFFERVESCENT / ORAL | 840 mg | ||
| ANHYDROUS CITRIC ACID | ANHYDROUS CITRIC ACID | XF417D3PSL | INJECTION / INTRAVENOUS | 1152 mg | ||
| POTASSIUM SORBATE | POTASSIUM SORBATE | 1VPU26JZZ4 | SYRUP / ORAL | 2 mg/1ml | ||
| POTASSIUM SORBATE | POTASSIUM SORBATE | 1VPU26JZZ4 | SOLUTION / RECTAL | 6.67 %w/v | ||
| POTASSIUM SORBATE | POTASSIUM SORBATE | 1VPU26JZZ4 | POWDER, FOR SUSPENSION / ORAL | 19 mg | ||
| ANHYDROUS CITRIC ACID | ANHYDROUS CITRIC ACID | XF417D3PSL | AEROSOL, FOAM / TOPICAL | 6 mg | ||
| POTASSIUM SORBATE | POTASSIUM SORBATE | 1VPU26JZZ4 | EMULSION / OPHTHALMIC | 0.47 %w/v | ||
| ANHYDROUS CITRIC ACID | ANHYDROUS CITRIC ACID | XF417D3PSL | INJECTION, SOLUTION, CONCENTRATE / INTRAVENOUS | 81 mg | ||
| ANHYDROUS CITRIC ACID | ANHYDROUS CITRIC ACID | XF417D3PSL | SOLUTION, CONCENTRATE / INTRAVENOUS | 60 mg | ||
| ANHYDROUS CITRIC ACID | ANHYDROUS CITRIC ACID | XF417D3PSL | AEROSOL / TOPICAL | 0.08 %w/w | ||
| POTASSIUM SORBATE | POTASSIUM SORBATE | 1VPU26JZZ4 | TABLET, FILM COATED, EXTENDED RELEASE / ORAL | 0.2 mg | ||
| ANHYDROUS CITRIC ACID | ANHYDROUS CITRIC ACID | XF417D3PSL | SYRUP / ORAL | 268 mg | ||
| ANHYDROUS CITRIC ACID | ANHYDROUS CITRIC ACID | XF417D3PSL | INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION / INTRAVENOUS | 414 mg | ||
| ANHYDROUS CITRIC ACID | ANHYDROUS CITRIC ACID | XF417D3PSL | FILM / SUBLINGUAL | 11 mg | ||
| ANHYDROUS CITRIC ACID | ANHYDROUS CITRIC ACID | XF417D3PSL | INJECTION / INFILTRATION | 0.02 %w/v | ||
| POTASSIUM SORBATE | POTASSIUM SORBATE | 1VPU26JZZ4 | SUSPENSION / ORAL | 400 mg | ||
| ANHYDROUS CITRIC ACID | ANHYDROUS CITRIC ACID | XF417D3PSL | CAPSULE, LIQUID FILLED / ORAL | 360 mg | ||
| POTASSIUM SORBATE | POTASSIUM SORBATE | 1VPU26JZZ4 | AEROSOL, FOAM / TOPICAL | 8 mg | ||
| ANHYDROUS CITRIC ACID | ANHYDROUS CITRIC ACID | XF417D3PSL | CAPSULE / ORAL | 131 mg | ||
| ANHYDROUS CITRIC ACID | ANHYDROUS CITRIC ACID | XF417D3PSL | CONCENTRATE / INTRAVENOUS | ADJ PH | ||
| ANHYDROUS CITRIC ACID | ANHYDROUS CITRIC ACID | XF417D3PSL | FILM, SOLUBLE / BUCCAL | 2 mg | ||
| ANHYDROUS CITRIC ACID | ANHYDROUS CITRIC ACID | XF417D3PSL | TABLET, ORALLY DISINTEGRATING / SUBLINGUAL | ADJ PH | ||
| ANHYDROUS CITRIC ACID | ANHYDROUS CITRIC ACID | XF417D3PSL | INJECTION / INTRAMUSCULAR | 101 mg | ||
| ANHYDROUS CITRIC ACID | ANHYDROUS CITRIC ACID | XF417D3PSL | SOLUTION / TOPICAL | 4.35 %w/v | ||
| ANHYDROUS CITRIC ACID | ANHYDROUS CITRIC ACID | XF417D3PSL | SOLUTION / OPHTHALMIC | 0.09 %w/v | ||
| ANHYDROUS CITRIC ACID | ANHYDROUS CITRIC ACID | XF417D3PSL | LOZENGE / TRANSMUCOSAL | 44 mg | ||
| POTASSIUM SORBATE | POTASSIUM SORBATE | 1VPU26JZZ4 | SOLUTION / ORAL | 1000 mg/15ml | ||
| ANHYDROUS CITRIC ACID | ANHYDROUS CITRIC ACID | XF417D3PSL | SUSPENSION / RECTAL | 904 mg | ||
| ANHYDROUS CITRIC ACID | ANHYDROUS CITRIC ACID | XF417D3PSL | INJECTION / PERINEURAL | 0.02 %w/v | ||
| ANHYDROUS CITRIC ACID | ANHYDROUS CITRIC ACID | XF417D3PSL | INJECTION, SOLUTION / INTRAMUSCULAR | 25 mg | ||
| ANHYDROUS CITRIC ACID | ANHYDROUS CITRIC ACID | XF417D3PSL | SUSPENSION / ORAL | 400 mg | ||
| POTASSIUM SORBATE | POTASSIUM SORBATE | 1VPU26JZZ4 | PASTE / ORAL | 48 mg | ||
| ANHYDROUS CITRIC ACID | ANHYDROUS CITRIC ACID | XF417D3PSL | POWDER, FOR SOLUTION / ORAL | 123 mg | ||
| ANHYDROUS CITRIC ACID | ANHYDROUS CITRIC ACID | XF417D3PSL | OIL / TOPICAL | 2 mg | ||
| ANHYDROUS CITRIC ACID | ANHYDROUS CITRIC ACID | XF417D3PSL | SHAMPOO / TOPICAL | 0.07 %w/w | ||
| ANHYDROUS CITRIC ACID | ANHYDROUS CITRIC ACID | XF417D3PSL | SOLUTION / ORAL | 3900 mg | ||
| ANHYDROUS CITRIC ACID | ANHYDROUS CITRIC ACID | XF417D3PSL | INJECTION / SUBCUTANEOUS | 101 mg | ||
| POTASSIUM SORBATE | POTASSIUM SORBATE | 1VPU26JZZ4 | TABLET / ORAL | 6 mg | ||
| POTASSIUM SORBATE | POTASSIUM SORBATE | 1VPU26JZZ4 | CONCENTRATE / ORAL | 1 mg | ||
| ANHYDROUS CITRIC ACID | ANHYDROUS CITRIC ACID | XF417D3PSL | POWDER, FOR SUSPENSION / ORAL | 570 mg | ||
| ANHYDROUS CITRIC ACID | ANHYDROUS CITRIC ACID | XF417D3PSL | TABLET, EXTENDED RELEASE / ORAL | 312 mg | ||
| ANHYDROUS CITRIC ACID | ANHYDROUS CITRIC ACID | XF417D3PSL | CREAM / TOPICAL | 1 mg | ||
| POTASSIUM SORBATE | POTASSIUM SORBATE | 1VPU26JZZ4 | SOLUTION/ DROPS / OPHTHALMIC | 0.47 %w/v | ||
| ANHYDROUS CITRIC ACID | ANHYDROUS CITRIC ACID | XF417D3PSL | SOLUTION/ DROPS / AURICULAR (OTIC) | 1 mg | ||
| ANHYDROUS CITRIC ACID | ANHYDROUS CITRIC ACID | XF417D3PSL | LIQUID / INTRAVENOUS | 18 mg | ||
| ANHYDROUS CITRIC ACID | ANHYDROUS CITRIC ACID | XF417D3PSL | ELIXIR / ORAL | 90 mg | ||
| ANHYDROUS CITRIC ACID | ANHYDROUS CITRIC ACID | XF417D3PSL | GRANULE, FOR SUSPENSION / ORAL | 30 mg | ||
| ANHYDROUS CITRIC ACID | ANHYDROUS CITRIC ACID | XF417D3PSL | SUSPENSION / RESPIRATORY (INHALATION) | 1 mg | ||
| ANHYDROUS CITRIC ACID | ANHYDROUS CITRIC ACID | XF417D3PSL | FILM / BUCCAL | 9 mg | ||
| POTASSIUM SORBATE | POTASSIUM SORBATE | 1VPU26JZZ4 | CREAM / TOPICAL | 0.25 %w/w |
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| 7df1e0ab-7208-05f3-e053-2991aa0ada93 | 5493cd3d-a021-4832-8941-27d2d7b625eb | 2018-12-26 | Warnings | 7df1e0ab-7208-05f3-e053-2991aa0ada93 5493cd3d-a021-4832-8941-27d2d7b625eb |
Adverse event summaries are temporarily unavailable. Other product information remains available.